Gorilla Technology Gr (NASDAQ:GRRR) reported quarterly losses of $(0.29) per share. The company reported $13.80 million in sales this quarter.
Alpine Immune Sciences To Present Updated Clinical Data For Povetacicept In IgA Nephropathy At The World Congress Of Nephrology 2024
-- The Company will present updated data in a late-breaking poster session for povetacicept in IgA nephropathy patients ---- The Company will host an investor event the same day concurrently with the poster presentation
